BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180529
DTEND;VALUE=DATE:20180701
DTSTAMP:20260730T103920
CREATED:20180529T095017Z
LAST-MODIFIED:20180529T095017Z
UID:20271-1527552000-1530403199@ces.b2sg.org
SUMMARY:Faculty Positions (DOQ)
DESCRIPTION:Huntsman Cancer Institute (HCI) and the Department of Oncological Sciences at the University of Utah Health Sciences Center seeks outstanding candidates for faculty positions at all levels and at all ranks in basic and translational cancer research. \nHCI is an NCI-designated Comprehensive Cancer Center and a member of the National Comprehensive Cancer Network (NCCN)\, supporting and fostering a vibrant research enterprise in a highly collegial environment. HCI has a strong history of academic achievement and impact as well as a commitment to excellence in patient care\, research\, teaching and service. \nHCI has made a strategic commitment to develop disease-oriented research teams (DOTs) as a mechanism to enhance translational research. DOTs specialize in adult and pediatric cancer research in the following areas: Colon Cancer\, Genitourinary and Hematologic Malignancies\, Hepatobiliary Cancer\, Melanoma\, Neuro-Oncology\, Pancreatic Cancer\, Sarcoma\, Upper Aero Digestive Tract (with existing strengths in lung cancer) and Women’s Cancers. Candidates whose research interests are aligned with these DOTs are strongly encouraged to apply. \n1. Basic Cancer Research:\nWe seek junior and senior investigators with innovative research programs in cancer-relevant biology that emphasize mechanistic approaches. Areas of interest include signal transduction\, stem cells\, gene regulation & transcription\, chromatin & epigenetics\, genome stability & DNA repair\, metabolism\, cancer genetics\, metastasis\, epithelial biology\, tumor immunology\, hematologic malignancies\, pediatric/youth cancers\, and mechanisms of therapy resistance. \n2. Translational Cancer Research:\nThis broad-based recruitment seeks outstanding junior or senior investigators in areas including\, but not limited to: animal models\, signal transduction\, cancer genetics\, target validation\, drug discovery & validation\, epigenetics & gene expression\, DNA damage & repair\, tumor immunology\, cancer initiating cells\, and clinical cancer research. Candidates whose scientific interests will synergize with the clinical strengths of the HCI DOTs are particularly encouraged to apply. \nHCI and the University Health Sciences Center provide access to state-of-the-art equipment and services through exceptional Core Facilities (see www.cores.utah.edu) that enhance both discovery and translational science. HCI offers state-of-the-art laboratories\, including a new 225\,000 sq. ft. research building that doubles the Institute’s research space\, which opened summer 2017. The University of Utah offers excellent graduate programs for training PhD and MD/PhD students. For more information about HCI\, visit www.huntsmancancer.org. \nApplicants for Assistant Professor are expected to hold MD\, PhD\, or MD/PhD (or equivalent)\, have received appropriate postdoctoral training\, and to have a track record of impact and research productivity. Applicants for senior positions should additionally have a strong record of independent funding and innovative research. HCI particularly encourages and welcomes applications from physician-scientists across the continuum of cancer research. Highly competitive recruitment packages are available with appointment and rank in an academic department at the University of Utah determined by the applicants’ qualifications. \nCandidates should submit a curriculum vitae\, cover letter containing a description of professional experience (including scientific accomplishments\, leadership responsibilities and 3 references)\, and a 2-3 page research plan. Applications will be accepted continuously\, with evaluations beginning November 10\, 2017\, until positions are filled or closed. \nTo apply online\, please visit the following link:\nhttp://utah.peopleadmin.com/postings/69239 \nOr\, send to:\nHuntsman Cancer Institute\nAttn: Recruitment Office\, Room 5160\n2000 Circle of Hope\, Salt Lake City\, UT 84112-5550\nEmail: hci.recruitment@hci.utah.edu \nFor questions\, please contact Natalie Angle at hci.recruitment@hci.utah.edu
URL:https://ces.b2sg.org/event/utah-29may18/
LOCATION:University of Utah\, 201 Presidents Cir\, Salt Lake City\, 84112\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/university-of-utah_416x416.png
END:VEVENT
END:VCALENDAR